Cargando…
Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients
Orlistat is recommended in the treatment of obesity, which is an independent risk factor for nonalcoholic fatty liver disease (NAFLD). The reported findings of orlistat in NAFLD are divisive. Recently, periostin is identified as an important regulatory molecule in the pathogenesis of obesity-induced...
Autores principales: | Ali Khan, Rashid, Kapur, Prem, Jain, Abhinav, Farah, Farrukh, Bhandari, Uma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328128/ https://www.ncbi.nlm.nih.gov/pubmed/28260907 http://dx.doi.org/10.2147/TCRM.S124621 |
Ejemplares similares
-
Mechanism of Orlistat Hydrolysis by the Thioesterase
of Human Fatty Acid Synthase
por: Fako, Valerie E., et al.
Publicado: (2014) -
Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023) -
Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011) -
Expression of periostin according to endometrial cancer grade
por: Herkiloglu, Dilsad, et al.
Publicado: (2022) -
Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007)